SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...

Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...

Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology firm specializing in biological products with a current market capitalization of $5.5 million, announced the appointment of... ByInvesting ...

Companies such as Organovo are pioneering the 'bioprinting' of human tissue, which is already being used to aid pharma drug development, and may one day allow replacement organs to be produced ...

After hours: January 3 at 7:31:41 p.m. EST ...

On 7 February 2024, Pandora announced a new share buyback programme, cf. Company announcement no. 843. The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the ...

Jan. 6, 2025 — New research shows that the sweeping land use changes and irrigation of the U.S. Corn Belt, along with the influence of the area's shallow ... Floods Linked to Rise in US Deaths ...

A state of emergency has been declared in Russia's western city of Engels, according to the region's governor. It comes after Ukraine said it was behind a drone strike on a Russian oil base in the ...

Fast-growing wildfires raging in Los Angeles killed at least two people on Wednesday, destroying hundreds of buildings, scorching hillsides and prompting officials to order some 70,000 people to ...

Jan. 3, 2025 — Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, ... Enzyme Promoting Tumor Growth ...